Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
7.11M
-
Shares change
-
-870K
-
Total reported value, excl. options
-
$63.5M
-
Value change
-
-$8.25M
-
Put/Call ratio
-
1.34
-
Number of buys
-
30
-
Number of sells
-
-47
-
Price
-
$8.93
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q4 2021
102 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q4 2021.
Co-Diagnostics, Inc. - Common Stock (CODX) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.11M shares
of 38.5M outstanding shares and own 18.44% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.8M shares), MILLENNIUM MANAGEMENT LLC (557K shares), Parametric Portfolio Associates LLC (549K shares), BlackRock Inc. (490K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (384K shares), Advisor Resource Council (296K shares), RENAISSANCE TECHNOLOGIES LLC (295K shares), GEODE CAPITAL MANAGEMENT, LLC (256K shares), Russell Investments Group, Ltd. (242K shares), and Bank of New York Mellon Corp (186K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.